The initial epidemiological data on HIV-associated dementia identified this disorder as a common occurrence in patients with HIV, affecting as many as 40% of the patients infected with HIV.

With the advent of antiretroviral therapy, the prevalence of these disorders has declined, especially in people who are on treatment consistently.

There is recent debate regarding the cause of persistent neurocognitive deficits in the post-HAART era. While some studies continue to outline the increased risk of neurocognitive disorders in patients with HIV,